USPTO serial 88358357
ENFUEGO THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2020
- Examiner
- CHISOLM, KEVON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ENFUEGO THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer and new cancer therapies using RNA interference; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of RNA in cells within a laboratory or research facility to enable gene expression manipulation to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Conducting research and clinical trials for others relating to the use and the engineering of RNA, DNA or the combination for cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes; providing a website featuring health and healthcare information related to cancer research | ACTIVE | Nov 17, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Enfuego Therapeutics, Inc.
- Other trademarks owned by Enfuego Therapeutics, Inc.
- Other trademarks owned by Enfuego Therapeutics, Inc.
- Other trademarks in Class 042
- Similar marks named ENFUEGO THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 12, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 8, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 14, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 14, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 25, 2020 | IUAF | USE AMENDMENT FILED | — |
| Feb 25, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 10, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 30, 2019 | NWAP | NEW APPLICATION ENTERED | — |